Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures

NCT06084689 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT06084689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06084689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures
Lead sponsor
Institut Bergonié
Phase
Phase 2
Overall status
Withdrawn
Start date
June 14, 2024
Completion date
July 1, 2024
Enrollment
0 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

adult soft tissue sarcoma, biliary tract cancer, colorectal cancer, non small cell lung cancer, triple negative breast cancer